当前位置:医学文献首页 >> 基础医学 >> 遗传学 >> 正文

肝纤维化和肝硬变基因治疗的研究现状 3

来源:医学杂志 2006-11-10 19:45:01 

orming growth factor-beta 1 concentrations in patients with chronic viral hepatitis.J Gastroenterol Hepatol,1998;13:680-684

  [11] Bernasconi P,Torchiana E,Confalonier P,Brugnoni R,Barresi R,Mora M, comelio F,Morandi R,Mantegazza R.Expression of transforming growth factor-beta1in dystrophic patient muscles correlates w role of a fibrogenic cytokine.J Clin invest,1995;96:1137-114

  [12]ascda Y, Matsumoto K,Yamada A,Ichida T,Asakura H,Komoriya Y,Nishiyama e,Nakamura T.Preventive and therapeutic effects in rats of Nishiyama E,Nakamura t.Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.Hepatology,1997;26:81-89

  [13]Friedman SL.Cytokines and fibrogensis.Semin Liver Dis,1999;19:129-140

  [14] Border WA,Noble NA.TGF-beta in kidney fibrosis:a target for gene therapy.Kidney Int,1997;5:1388-1396

  [15]letal muscle expression of decorin prevents fibrotic disease in rat kidney.Nat Med,1996;2:418-423

  [16] Inoue T,Nabeshima K,,Shima Y,Koono M.Hepatocyte growth factor/Scatter factor(HGF/SF)is a regulator of fibronectin splicing in MDCK cells:comparison between the effects of HGF/SF and TGF-beta 1 on fi splicing at the EDA region.Biochem Biophys Res Commun,260:225-231

  [17]Li D,Friedman SL.Liver fibrogenesis and the role of hepatic stellate cells:new insights and prospects for therapy.J Gastroenterol hepatol,1999;14:618-633

[1] [2] [3]
今日推荐
返回频道首页
相关图片

热点文章